Advertisement
Screener

PROFOUND MEDICAL CORP. (PROF) Adjustments For Decrease Increase In Trade Account Receivable

2.8 / 5 stars · 68/120 Roast Me

PROFOUND MEDICAL CORP. Adjustments For Decrease Increase In Trade Account Receivable

PROFOUND MEDICAL CORP. (PROF) reported Adjustments For Decrease Increase In Trade Account Receivable of -$956.00 thousand for the 12-month period ending 2023-12-31, per its 40-F filed 2024-03-07.

Discontinued › Notes › Receivables

ifrs-full:AdjustmentsForDecreaseIncreaseInTradeAccountReceivable · last filed 2024-03-07

CAD

Period endAdjustments For Decrease Increase In Trade Account Receivable 12 month
2019-12-31-1.37M CAD
40-F · filed 2020-03-03
2018-12-311.57M CAD
40-F · filed 2020-03-03

USD

Period endAdjustments For Decrease Increase In Trade Account Receivable 12 month
2023-12-31-$956.00K
40-F · filed 2024-03-07
2022-12-31-$1.42M
40-F · filed 2024-03-07
2021-12-31$2.00M
40-F · filed 2023-03-07
2020-12-31-$4.03M
40-F · filed 2022-03-03
2019-12-31-$1.03M
40-F · filed 2021-03-02

Similar stocks

Stock NameCountryMarket CapPE Ratio
Neuronetics, Inc. (STIM)United States$0.216B-3.25
PRO DEX INC (PDEX)United States$0.234B13.64
UTAH MEDICAL PRODUCTS INC (UTMD)United States$0.238B20.93
Lucid Diagnostics Inc. (LUCD)United States$0.170B
InfuSystem Holdings, Inc (INFU)United States$0.253B22.52
KORU Medical Systems, Inc. (KRMD)United States$0.151B-106.78
Anika Therapeutics, Inc. (ANIK)United States$0.272B-51.71
ORASURE TECHNOLOGIES INC (OSUR)United States$0.272B-6.26
Cytosorbents Corp (CTSO)United States$0.274B-1.29
TriSalus Life Sciences, Inc. (TLSI)United States$0.283B-9.92